095L3ZZ
Destruction Nasal Turbinate to No Qualifier with No Device, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 9 Ear, Nose, Sinus |
| Operation | 5 Destruction |
| Body Part | L Nasal Turbinate |
| Approach | 3 Percutaneous |
| Device | Z No Device |
| Qualifier | Z No Qualifier |
Operation Definition
Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent
Procedure Overview
This family covers eradicating tissue in the ear, nose, or sinuses using energy, heat, cold, or a chemical agent, without physically cutting the tissue out and removing it from the body. Turbinate tissue that is contributing to chronic nasal obstruction is a typical target, ablated in place with radiofrequency energy, laser, or cautery so that it shrinks and scars down rather than being excised.
Patients pursue these procedures for issues such as chronic nasal congestion from enlarged turbinates, recurrent nosebleeds from a fragile vessel, or small growths that respond well to ablation rather than cutting. Because the tissue is destroyed in place rather than removed as a specimen, recovery is often quicker than with excisional surgery, though the treated tissue remains in the body and is expected to be reabsorbed or scarred down over time.
Anatomy & Axis Detail
Nasal Turbinate
The nasal turbinates are the paired bony ridges covered in vascular mucosa that project into the nasal cavity to humidify, warm, and filter inhaled air. When they become chronically enlarged from allergic rhinitis or vasomotor rhinitis and cause persistent nasal obstruction unresponsive to medical therapy, destruction of the excess mucosal and submucosal tissue - through radiofrequency ablation, coblation, or cautery - can shrink turbinate volume and improve airflow while preserving the underlying bone and overall turbinate function. This distinguishes the procedure from a turbinectomy, which removes turbinate tissue outright. Because turbinate tissue is engorged with blood vessels, controlling bleeding during the ablative pass is a routine part of the technique, and documentation should note whether the inferior, middle, or another turbinate was treated.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Coding & Documentation
Coders should look for language indicating the tissue was ablated, cauterized, coagulated, fulgurated, or otherwise destroyed in place, with no mention of the tissue being excised and sent to pathology. The operative note should identify both the specific site and the destructive modality used, such as radiofrequency, laser, or chemical cautery. The most common assignment error is coding Destruction when a lesion or polyp was actually cut away and removed as a specimen, which belongs under Excision or Resection instead. A second common error is applying Destruction to a hemostatic cautery performed purely to stop bleeding, which is more accurately Control when no tissue eradication was the goal, or missing that submucosal turbinate reduction procedures are described several different ways across operative notes even though they all describe the same destructive intent.